The antiepileptic drug lamotrigine is a substrate of breast cancer resistance protein

被引：0
作者：
Roemermann, Kerstin [1 ]
Fedrowitz, Maren [1 ]
Loscher, Wolfgang [1 ,2 ]
机构：
[1] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany
[2] Ctr Syst Neurosci, Hannover, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2014年 / 387卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
319
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [41] Dual-pocket inhibition of Nav channels by the antiepileptic drug lamotrigine
    Huang, Jian
    Fan, Xiao
    Jin, Xueqin
    Teng, Liming
    Yan, Nieng
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (41)
  • [42] The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
    Mark P. van Opijnen
    Pim B. van der Meer
    Linda Dirven
    Marta Fiocco
    Mathilde C. M. Kouwenhoven
    Martin J. van den Bent
    Martin J. B. Taphoorn
    Johan A. F. Koekkoek
    Journal of Neuro-Oncology, 2021, 154 : 73 - 81
  • [43] circRNAs in drug resistance of breast cancer
    Misir, Sema
    Yaman, Serap Ozer
    Petrovic, Nina
    Sumer, Ceren
    Hepokur, Ceylan
    Aliyazicioglu, Yuksel
    ONCOLOGY RESEARCH, 2022, 30 (04) : 157 - 172
  • [44] Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists
    Sugimoto, Y
    Tsukahara, S
    Imai, Y
    Sugimoto, Y
    Ueda, K
    Tsuruo, T
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (01) : 105 - 112
  • [45] The Antiepileptic Drug Topiramate is a Substrate for Human P-glycoprotein but Not Multidrug Resistance Proteins
    Carlos Luna-Tortós
    Bernhard Rambeck
    Uwe H. Jürgens
    Wolfgang Löscher
    Pharmaceutical Research, 2009, 26 : 2464 - 2470
  • [46] Ticagrelor markedly increases plasma concentrations of the breast cancer resistance protein substrate rosuvastatin
    Lehtisalo, Minna
    Tarkiainen, Katriina
    Lapatto-Reiniluoto, Outi
    Holmberg, Mikko
    Neuvonen, Mikko
    Kurkela, Mika
    Kiiski, Johanna
    Backman, Janne T.
    Niemi, Mikko
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 132 : 22 - 22
  • [47] Exosomes and breast cancer drug resistance
    Dong, Xingli
    Bai, Xupeng
    Ni, Jie
    Zhang, Hao
    Duan, Wei
    Graham, Peter
    Li, Yong
    CELL DEATH & DISEASE, 2020, 11 (11)
  • [48] Understanding Drug Resistance in Breast Cancer
    Maduro, Maria Rosa
    REPRODUCTIVE SCIENCES, 2014, 21 (01) : 5 - 5
  • [49] Studies on the Intestinal Absorption Characteristics of Sulfasalazine, a Breast Cancer Resistance Protein (BCRP) Substrate
    Tomaru, Atsuko
    Morimoto, Nozomi
    Morishita, Mariko
    Takayama, Kozo
    Fujita, Takuya
    Maeda, Kazuya
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (01) : 71 - 74
  • [50] The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein
    Goncalves, Pedro
    Gregorio, Ines
    Martel, Fatima
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2011, 301 (05): : C984 - C994
12345